Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.

Journal for immunotherapy of cancer(2023)

引用 0|浏览22
暂无评分
摘要
NCT02301611.
更多
查看译文
关键词
tlpldc vaccines,prospective melanoma,double-blind
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要